Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1, Phase 2]
Phase 1/2 trial evaluating autologous cytokine-induced killer cell adoptive immunotherapy for acute myeloid leukemia and myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies [Phase 1, Phase 2]
Phase 1 and Phase 2 results are reported for allogeneic cytokine-induced killer (CIK) cell immunotherapy given to patients who relapsed afte…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating azacitidine in combination with lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Study of the Glutaminase Inhibitor CB-839 in Leukemia [Phase 1]
This document provides a Phase 1 trial update for CB-839, a glutaminase inhibitor, in patients with acute myeloid leukemia and acute lymphob…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients [NA]
A completed clinical trial evaluating the effectiveness of the neutropenic diet in pediatric oncology patients, including acute lymphoblasti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients [Phase 2]
Phase 2 clinical trial evaluating the combination of cytarabine (Ara-C) and aclarubicin with pegylated G-CSF (PEG-G-CSF) as initial treatmen…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia [Phase 1]
Phase 1 pilot trial of lenalidomide in adult Diamond-Blackfan anemia patients with transfusion-dependent anemia. The study was terminated an…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP)
A completed prospective pilot study at West Virginia University analyzed bone marrow and peripheral blood from acute myeloid leukemia patien…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia [Phase 2]
This update summarizes the results of a Phase 2 clinical trial evaluating idarubicin with high-dose cytarabine in patients with acute myeloi…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]
Phase 3 trial evaluating daunorubicin, cytarabine, and midostaurin in newly diagnosed acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid Leukemia
This completed clinical trial analyzed factors associated with the development of severe sepsis in patients being treated for acute myeloid …
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating ribavirin plus low-dose cytarabine for acute myeloid leukemia has completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Physical Conditioning and Decitabine for Newly Diagnosed AML Patients Age ≥ 60 [Phase 1]
Phase 1 trial update on decitabine with physical conditioning for newly diagnosed acute myeloid leukemia patients aged 60 and older. The stu…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk [Phase 3]
Phase 3 trial update evaluating the efficacy of gemtuzumab ozogamicin in adults with intermediate-risk acute myeloid leukemia; the study has…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia [Phase 1]
Phase 1 study of RO5503781 as a single agent or in combination with cytarabine in participants with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) [Phase 1]
Phase 1 study of SCH 900776 (MK-8776) with and without cytarabine in acute leukemias; the trial is terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT [Phase 1, Phase 2]
The document reports the completion of a Phase 1/2 trial evaluating a TCR alpha-beta depleted graft in pediatric patients with acute lymphob…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21) [Phase 4]
Phase 4 clinical trial update comparing Decitabine maintenance therapy to conventional chemotherapy in patients with acute myeloid leukemia …
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: DTGM Fusion Protein in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial of DTGM Fusion Protein in patients with recurrent or refractory acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML Trial
A clinical trial evaluating sorafenib for relapsed FLT3-ITD acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: Physical Activity as Self-Management Approach to Improve Health Outcomes in AML [NA]
A completed clinical trial evaluated physical activity as a self-management approach to improve health outcomes in acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias
This completed clinical trial investigates protein biomarker profiles in neutropenic fever/infection among patients with acute or chronic le…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial
An observational study (ALLIVE) completed that evaluated body, liver, and labile plasma iron metrics and their associations with clinical ou…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Safety Study of Thioridazine in Combination With Cytarabine to Treat Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
A completed Phase 1 safety trial evaluated the combination of thioridazine and cytarabine in relapsed or refractory acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia [Phase 3]
Phase 3 clinical trial evaluating decitabine in combination with low-dose cytarabine for elderly patients with acute myeloid leukemia; curre…